Zhilan Hu

Title: Zhilan Hu: Innovator in Tumorigenesis Research

Introduction

Zhilan Hu is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of genetics, particularly in understanding the role of the sonic hedgehog gene in tumorigenesis. His work has implications for cancer research and therapeutic development.

Latest Patents

Zhilan Hu holds a patent for a mutant human hedgehog gene. This mutation is associated with various human tumors, including basal cell carcinomas, breast carcinomas, and medulloblastomas. The patent details how a somatic mutation results in an amino acid substitution at position 133, or a mutation at position 114. Such mutated genes and fragments, along with the encoded protein and specific antibodies, are useful in characterizing the phenotype of associated tumors. The mutant protein has applications in drug screening for compositions that modulate hedgehog activity or expression. Additionally, the encoded protein can be utilized therapeutically to influence cell proliferation and differentiation, as well as to treat conditions linked to decreased hedgehog signaling.

Career Highlights

Zhilan Hu is affiliated with the University of California, where he continues to advance his research in genetics and tumor biology. His innovative work has garnered attention in the scientific community, contributing to a deeper understanding of cancer mechanisms.

Collaborations

Zhilan has collaborated with notable colleagues, including Ervin H Epstein, Jr. and Jeanette Bonifas, who is a distinguished woman in the field. Their combined expertise enhances the research efforts in understanding tumorigenesis and developing potential therapies.

Conclusion

Zhilan Hu's contributions to the field of genetics and tumorigenesis are noteworthy. His patent on the mutant human hedgehog gene represents a significant advancement in cancer research. Through his work at the University of California and collaborations with esteemed colleagues, he continues to impact the scientific community positively.